Delivery Order SPE2DB20D3505-SPE2DB22FT6S5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,182.62 firm fixed-price delivery order contract is for the supply of Depakote DR 250 mg tablets. The contract has an ultimate completion date of August 24, 2022 and was awarded on August 23, 2022. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,161.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DEPAKOTE ER 250 MG TABLET 100S, with an ultimate completion date of October 29, 2024. The contract type is Firm Fixed Price, and no set-aside designation was used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This contract award, SPE2DB22D3016|SPE2DB25FAJV0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,579.83 firm fixed-price delivery order is for the supply of 100 units of DEPAKOTE ER 250 MG TABLET, a medication used for various medical conditions. The award is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,472.71 firm fixed-price delivery order covers the supply of Depakote DR 125 mg sprinkle capsules. The contract has an ultimate completion date of March 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,757.85 firm fixed-price delivery order is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a pharmaceutical product. The contract has a completion date of July 26, 2022 and was awarded on July 25, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Depakote DR 125 mg sprinkle capsules. The Delivery Order, valued at $1,350.72, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,383.36 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. This contract is for the delivery of 4,563,172,594 units of the prescription medication Depakote DR 250 mg tablets. The contract has a completion date of December 26, 2023 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC1G9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Depakote ER 250 mg tablets, a medication used to treat certain types of seizures. The contract has a firm fixed price, with a ceiling value of $2,912.28, and an ultimate completion date of May 6, 2025. This...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 27, 2026, for $2,007.78 to supply Depakote DR 500 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 28, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT6S5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,328.59 firm fixed-price delivery order covers the supply of DEPAKOTE DR 250 MG TABLET 100S, a medication used to treat certain types of seizures. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have any set-aside designations, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/12/22 |